What is Spravato?
Spravato (esketamine) is a brand-name nasal spray containing the active drug esketamine. It is a prescription medication approved by the FDA for treating certain types of depression in adults, specifically treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal thoughts or actions. Like intravenous Ketamine, Spravato belongs to a class of drugs called NMDA receptor blockers and is always prescribed in conjunction with at least one other oral antidepressants. It is supplied as a nasal solution in 28 mg sprays and is available in 56 mg and 84 mg dose kits.
SGB helps many patients get relief from some or all of the following:
Get all of your questions answered by booking a free phone consultation
Frequently asked questions (FAQ)
Spravato is a nasal spray medication containing esketamine (Ketamine), used to treat treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal ideations. It is administered in one of our clinics and supervised by licensed clinical staff.
Spravato is administered under the supervision of a healthcare provider in our clinics. Patients self-administer the nasal spray and are monitored for at least two hours afterward to manage potential side effects.
The dosing schedule typically involves twice-weekly treatments for the first month, once-weekly treatments for the second month, and then once every week or two weeks thereafter.
No, it is recommended not to drive on the day of the procedure due to potential side effects. Arrange for someone to drive you home and stay with you for the rest of the day if needed.
Spravato has been shown to improve depressive symptoms rapidly, often within weeks, making it effective for treatment-resistant cases.
Common side effects include sedation, dissociation, nausea, dizziness, and increased blood pressure. Serious side effects can include problems with thinking clearly and bladder issues.
Yes. However, avoid strenuous activities on the day of the procedure and follow any specific post-procedure instructions from your CIT Clinics provider.
Yes, you should avoid food for a certain period before the procedure (typically 6 hours) and clear fluids up to 2 hours before. Specific instructions will be provided during your onboarding process and treatment preparation.
While Spravato is a controlled substance due to its potential for abuse, there is no evidence of addiction when used at prescribed doses in a certified medical setting.